Back to Results
First PageMeta Content
Pharmaceutical industry / Immunosuppressants / Monoclonal antibodies / Pharmaceuticals policy / Ribavirin / Novartis / Infliximab / Clinical trial / Metformin / Pharmacology / Pharmaceutical sciences / Medicine


Tuesday, July 31, 2012 from 6:00pm to 6:35pm [Attendees] Ken-kichi Kosakai, Board Director and Managing Executive Officer, Corporate Management Masayuki Mitsuka, Board Director and Managing Executive Officer, Division Ma
Add to Reading List

Document Date: 2012-08-06 23:18:00


Open Document

File Size: 41,86 KB

Share Result on Facebook
UPDATE